Dasatinib Dasatrue 50mg Tablet About
Dasatinib Dasatrue 50mg Tablet embodies a distinguished therapeutic choice for adults combating Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Produced in India and marketed for global export, this sublime antineoplastic agent utilizes the valorous efficacy of dasatinib to help manage leukemia. These ephemeral yet powerful tablets offer a reduced price without compromising on quality, making them accessible for international markets. Dasatrue requires a prescription and is formulated for oral administration. Always consult your physician, as side effects may include fluid retention, nausea, or rash. Store below 30C.
Advantages and Site of Application
Dasatinib Dasatrue 50mg Tablet offers a sublime advantage in the targeted treatment of leukemia. Intended for oral administration, the site of application is the gastrointestinal tract. The application surface is ideal for adults diagnosed with CML or ALL, ensuring distinguished systemic absorption. As a prescription-only medication, it is recommended strictly under medical supervision for adults requiring valorous and effective cancer therapy.
Packaging, Sample Policy, and Supply Ability
Each box contains 60 tablets, ensuring stock ready for efficient distribution. Dasatrue is securely packed to safeguard against light and moisture, with packaging designed for international standards. Samples may be available upon request and charges may apply according to the shipped destination. Supported by reliable transport services, supply ability meets demands across Canada, EU, UK, USA, and Australia, ensuring continuous and smooth delivery.
FAQ's of Dasatinib Dasatrue 50mg Tablet:
Q: How should Dasatinib Dasatrue 50mg Tablet be taken for effective results?
A: Dasatinib Dasatrue 50mg Tablet should always be taken orally, exactly as directed by your physician. It is crucial not to change your dosage or stop the medication without medical approval.
Q: What is Dasatinib Dasatrue 50mg Tablet prescribed for?
A: It is prescribed for adults diagnosed with certain types of leukemia, specifically Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL).
Q: When should I avoid taking Dasatinib Dasatrue 50mg Tablet?
A: You should avoid taking this medication during pregnancy or breastfeeding. Always inform your doctor about any medical conditions or other medications you are taking before starting therapy.
Q: Where can Dasatinib Dasatrue 50mg Tablet be exported?
A: It is available for global export and can be supplied to Canada, the EU, UK, USA, Australia, and other markets, subject to local product registration requirements.
Q: What side effects may be associated with Dasatinib Dasatrue 50mg Tablet?
A: Possible side effects include fluid retention, nausea, rash, and diarrhea. If you experience severe or persistent symptoms, consult your physician promptly.
Q: How is the product packaged and stored for quality assurance?
A: Dasatrue tablets are packaged in a box of 60 tablets, designed to protect from light and moisture. Store below 30C and always check the expiry date on the packaging.